UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030439
Receipt number R000034755
Scientific Title Evaluation study for the effect of transcranial direct current stimulatoin on brain function
Date of disclosure of the study information 2018/01/01
Last modified on 2022/06/22 12:43:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation study for the effect of transcranial direct current stimulatoin on brain function

Acronym

Evaluation study for the effect of tDCS

Scientific Title

Evaluation study for the effect of transcranial direct current stimulatoin on brain function

Scientific Title:Acronym

Evaluation study for the effect of tDCS

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the differences between single and recurrent tDCS

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

brain function evaluated by functional MRI at pre and post stimulation

Key secondary outcomes

Comparison between pre and post stimulation
higher brain function
degree of fatigue
evaluation for stress


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Non-randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

1. single tDCS (20 minutes)
2. wash-out 48hours
3. single sham stimulation (20 minutes)

Interventions/Control_2

1. single sham stimulation (20 minutes)
2. wash-out 48hours
3. single tDCS (20 minutes)

Interventions/Control_3

1. 10 days tDCS (20 minutes)
2. wash-out 2 weeks
3. 10 days sham stimulation(20 minutes)

Interventions/Control_4

1. 10 days sham stimulation (20 minutes)
2. wash-out 2 weeks
3. 10 days tDCS (20 minutes)

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >

Gender

Male and Female

Key inclusion criteria

Subjects who have the ability to provide informed consent and adhere to the protocol.

Key exclusion criteria

- Subject with past or current history of psychiatric illness
- Subject with past or current history of serious medical illness and/or brain organic diseases
- Subject who is contraindicated for the use of MRI
- Subject with past or current history ofsevere liver disease, kidney disease, heart disease, allergy, or severe drug allergy
- Subject who are judged as not suitable for participation in this study

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Yoshiro
Middle name
Last name Okubo

Organization

Nippon Medical School

Division name

Department of Neuropsychiatry

Zip code

113-8602

Address

1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan

TEL

+81-3-3822-2131

Email

okubo-y@nms.ac.jp


Public contact

Name of contact person

1st name Amane
Middle name
Last name Tateno

Organization

Nippon Medical School

Division name

Department of Neuropsychiatry

Zip code

113-8602

Address

1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan

TEL

+81-3-3822-2131

Homepage URL


Email

amtateno@nms.ac.jp


Sponsor or person

Institute

Nippon Medical School

Institute

Department

Personal name



Funding Source

Organization

anti-doping consortium

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nippon Medical School Hospital Institutional Review Board

Address

1-1-5, Sendagi, Bunkyo-ku, Tokyo, Japan

Tel

+81-3-3822-2131

Email

clinicaltrial@nms.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 01 Month 01 Day


Related information

URL releasing protocol

https://onlinelibrary.wiley.com/doi/10.1111/pcn.13208

Publication of results

Published


Result

URL related to results and publications

https://onlinelibrary.wiley.com/doi/10.1111/pcn.13208

Number of participants that the trial has enrolled

19

Results

Reaction times of the implicit motor learning task were significantly faster with tDCS in comparison with the sham. Further, language-related left prefrontal-parahippocampal-parietal activation was significantly less with tDCS compared with the sham. Significant correlation was observed between shortened response time in serial reaction time task and decreased cerebral activation during VFT with tDCS.

Results date posted

2022 Year 06 Month 22 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Nineteen healthy volunteers (eight females; mean age 23.1 years).

Participant flow

Nineteen healthy volunteers participated in the present study. Informed consent was obtained from all participants. Three participants were excluded due to mistakes with the motor learning task. A total of 16 participants were thus eventually included in the analyses.

Adverse events

none

Outcome measures

Motor learning task:
1. serial reaction time task
2. sequential finger tapping task

verbal fluency test

functional imaging by MRI

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 09 Month 27 Day

Date of IRB

2017 Year 12 Month 04 Day

Anticipated trial start date

2018 Year 01 Month 10 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry

2019 Year 05 Month 31 Day

Date trial data considered complete

2019 Year 07 Month 31 Day

Date analysis concluded

2019 Year 09 Month 30 Day


Other

Other related information



Management information

Registered date

2017 Year 12 Month 17 Day

Last modified on

2022 Year 06 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034755


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name